Business Context and Reporting Period
Company: ILLUMINA, INC.
Filing Type: Form 8-K (Current Report)
Date of Report: January 13, 2026
Reporting Period: Fourth quarter and fiscal year ended December 28, 2025.
Context: This filing announces the issuance of a press release containing unaudited preliminary financial results in advance of a presentation at the J.P. Morgan Healthcare Conference.
Key Financial Metrics
The provided filing text serves as a cover document referencing a press release (Exhibit 99.1) for detailed data. The text of this 8-K does not contain specific numerical values for the following metrics:
- Revenue
- Profit (Net Income)
- Cash Flow
- Margins
- Debt and Liquidity
Note: Specific financial figures are not present in the provided source text; they are contained within the referenced Exhibit 99.1.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. It only confirms that preliminary results for the fourth quarter and full fiscal year 2025 have been issued.
Guidance, Outlook, and Risks
Management Commentary: The Company issued a press release regarding preliminary results. A webcast presentation was held at the J.P. Morgan Healthcare Conference in San Francisco, California.
Legal Disclaimer: The information furnished pursuant to Item 2.02 (including the press release) is not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liabilities of that Section. It shall not be incorporated by reference into any Securities Act or Exchange Act filings.
Guidance/Risks: No specific forward-looking guidance, risk factors, or contingencies are detailed in the text of this 8-K.
Investor Verification Checklist
- Verify the specific revenue and profit figures in the attached Press Release (Exhibit 99.1), as they are not listed in the 8-K body.
- Review the J.P. Morgan Healthcare Conference webcast for management commentary on the preliminary results.
- Confirm the unaudited nature of the reported figures before making investment decisions.
- Check for any subsequent filings that may update the preliminary data or provide audited results.